en.unionpedia.org

Minodronic acid, the Glossary

Index Minodronic acid

Minodronic acid is a third-generation bisphosphonate drug.[1]

Table of Contents

  1. 5 relations: Bisphosphonate, Dimethylallyltranstransferase, Enzyme inhibitor, Mechanism of action, Osteoporosis.

  2. Bisphosphonates
  3. Imidazopyridines

Bisphosphonate

Bisphosphonates are a class of drugs that prevent the loss of bone density, used to treat osteoporosis and similar diseases. Minodronic acid and Bisphosphonate are Bisphosphonates.

See Minodronic acid and Bisphosphonate

Dimethylallyltranstransferase

Dimethylallyltranstransferase (DMATT), also known as farnesylpyrophosphate synthase (FPPS) or as farnesyldiphosphate synthase (FDPS), is an enzyme that in humans is encoded by the FDPS gene and catalyzes the transformation of dimethylallylpyrophosphate (DMAPP) and isopentenyl pyrophosphate (IPP) into farnesylpyrophosphate (FPP).

See Minodronic acid and Dimethylallyltranstransferase

Enzyme inhibitor

An enzyme inhibitor is a molecule that binds to an enzyme and blocks its activity.

See Minodronic acid and Enzyme inhibitor

Mechanism of action

In pharmacology, the term mechanism of action (MOA) refers to the specific biochemical interaction through which a drug substance produces its pharmacological effect.

See Minodronic acid and Mechanism of action

Osteoporosis

Osteoporosis is a systemic skeletal disorder characterized by low bone mass, micro-architectural deterioration of bone tissue leading to more porous bone, and consequent increase in fracture risk.

See Minodronic acid and Osteoporosis

See also

Bisphosphonates

Imidazopyridines

References

[1] https://en.wikipedia.org/wiki/Minodronic_acid

Also known as C9H12N2O7P2, Minodronate, YM 529.